A new report from the Peterson Health Technology Institute analyzed eight digital diabetes management tools. It found that the tools don't provide meaningful clinical benefits and increase healthcare spending.
The Peterson Health Technology Institute will function as an “independent evaluator” of digital health solutions. It will analyze solutions' clinical effectiveness, how they’re affecting healthcare costs, their ability to improve health equity, and their privacy and security capabilities.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.